The Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-2): A progress report

Blood Pressure

Volumn 5, Issue 5, 1996, Pages 300-304

  Lindholm, Lars H ^a   Hansson, Lennart ^b   Dahlöf, Björn ^c   Ekbom, Tord ^a   Hedner, Thomas ^c   De Faire, Ulf ^d   Scherstén, Bengt ^a   Wester, P O ^e  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACE inhibitors; Beta blockers; Calcium antagonists; Diuretics; Elderly; Hypertension; Mortality rate

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; GERIATRIC CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SMOKING;

EID: 0029778444     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609078063     Document Type: Article

References (20)

1. Kannel WB. Prevalence, incidence and hazards of hypertension in the elderly. Ger Cardiovasc Med 1988; 1: 5-10.
2. Holme I, Waaler HT. Five-year mortality in the city of Bergen, Norway, according to age. sex, and blood pressure. Acta Med Scand 1976; 200: 229-39.
3. Agner E. Predictive value of arterial blood pressure in old age. A ten-year prospective study of men and women born in 1897 and examined at the age of 70 and 80 years. Acta Med Scand 1983; 214: 285-94.
4. Amery A, Birkenhäger W, Brixko P, Bullpit C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1: 1349-54.
5. SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-64.
6. Dahlöf B, Lindholm L, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-12.
8. Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P, Hansson L. et al. (Guidelines subcommittee). The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Pressure 1993; 2: 86-100.
9. Psaty BM, Heckbert SR, Koepsell TD, Siscovic DS, Raghuanathan TE, Weiss NS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-5.
10. Buring JE, Glynn RJ, Hennekens CH (editorial). Calcium channel blockers and myocardial infarction. A hypothesis formulated but not vet tested. JAMA 1995; 274: 654-5.
11. Lenfant C. The calcium channel blocker scare Lessons for the future. Circulation 1995; 91: 2855-6.
12. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
13. Horton R (editorial). Spinning the risks and benefits of calcium antagonists. Lancet 1995; 346: 586.
14. Pahor M, Guralnik JM, Corti M, Foley DJ, Carboni P, Havlik RJ. Long-term survival and use of antihypertensive medication in older persons. J Am Ger Soc 1995; 43: 1-7.
15. Mancia G. van Zwieten P (editorial). How safe are calcium antagonists in hypertension and coronary heart disease? Hypertens 1996, 14: 13-7.
16. Hansson L, Hedner T, Dahlöf B. Prospective Randomised Open Blinded Endpoint (PROBE) study: a novel design for intervention trials. Blood Pressure 1992; 1: 113-9.
17. Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO, Ekbom T, et al STOP Hypertension-2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Blood Pressure 1993; 2: 136-41.
18. Hansson L, Dahlöf B. Calcium antagonists in the treatment of hypertension. State of the art. J Cardiovasc Pharmacol 1990; 15 (Suppl 4): S71-S15.
19. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients - meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-100.
20. Hansson L, Zanchetti for the HOT Study Group. The Hypertension Optimal Treatment Study: 12 month data on blood pressure and tolerability. With special reference to age and gender. Blood Pressure 1995; 4: 313-9.